Detail
| RLID: | RLID00029515 |
| RNA Symbol: | hsa-miR-30d-5p |
| RNA Category: | miRNA |
| Organism: | Homo sapiens |
| Aliase: | hsa-miR-30d |
| Subcellular Localization: | |
| Localization | Tissue | Validated Method | PMID |
| Circulating | Serum | Next-generation sequencing | 20194856 |
| Description: Endogenous circulating miRNAs are stable, are well protected from RNases, and remain stable even after being subjected to harsh conditions. Eleven serum miRNAs were found to be altered more than five-fold by Solexa sequencing between longer-survival and shorter-survival groups, and levels of four miRNAs (ie, miR-486, miR-30d, miR-1 and miR-501) were significantly associated with overall survival. | |||
Other Subcellular Localization:
| RLID | Localization | Tissue | Validated Method | PMID |
| RLID00029516 | Circulating | Cerebrospinal fluid | Next-generation sequencing|RT-PCR | 23525801 |
| RLID00029517 | Circulating | Serum | Next-generation sequencing|RT-PCR | 23525801 |
| RLID00029518 | Circulating | Serum | Next-generation sequencing | 23641832 |
| RLID00029519 | Cytoplasm | Nasopharyngeal carcinoma cell | Next-generation sequencing | 20498841 |
| RLID00029520 | Extracellular vesicle | HEK293T|HMEC-1|Mononuclear cell | Next-generation sequencing | 22849433 |
| RLID00029521 | Exosome | Serum | Microarray | 18589210 |
| RLID00029522 | Exosome | Breast cancer cell | Microarray | 20976003 |
| RLID00029523 | Exosome | B cell | Microarray | 21505438 |
| RLID00029524 | Exosome | Malignant melanoma cell | Microarray | 23056502 |
| RLID00029525 | Exosome | Brain tissue | Microarray | 23382797 |
| RLID00029526 | Exosome | Plasma | Next-generation sequencing | 23663360 |
| RLID00029527 | Microvesicle | Plasma | qRT-PCR | 19002258 |
| RLID00029528 | Microvesicle | Plasma | Next-generation sequencing | 23077538 |
| RLID00029529 | Microvesicle | Seminal Plasma | Microarray | 23539611 |
| RLID00029530 | Microvesicle | Follicular fluid | Microarray | 23666971 |
| RLID00029531 | Microvesicle | Hepatoma cell | qRT-PCR|Microarray | 23771658 |
| RLID00029532 | Mitochondrion | HeLa cell | Next-generation sequencing | 22984580 |
| RLID00029533 | Mitochondrion | Eembryonic kidney cell | Next-generation sequencing | 22984580 |
| RLID00029534 | Nucleus | Nasopharyngeal carcinoma cell | Next-generation sequencing | 20498841 |
| RLID00029535 | Nucleus | HeLa cell | Next-generation sequencing | 22058130 |
| RLID00029536 | Exosome | Cerebrospinal fluid | Next-generation sequencing | 25420022 |
| RLID00029537 | Nucleolus | HeLa|MCF7 | Microarray | 24918059 |
| RLID00029538 | Exosome | Serum | Next-generation sequencing | 24683445 |
| RLID00029539 | Exosome | Plasma | Next-generation sequencing | 24683445 |
| RLID00029540 | Cytoplasm | HeLa|MCF7 | Microarray | 24918059 |
| RLID00029541 | Microvesicle | A549|HepG2 | Microarrays|RT-PCR | 20615901 |
| RLID00029542 | Exosome | A549|HepG2 | Microarrays|RT-PCR | 20615901 |
| RLID00029543 | Exosome | Renal carcinomas cell | - | 22529849 |
| RLID00029544 | Exosome | Epithelial cell | - | 22529849 |
| RLID00029545 | Exosome | Liver carcinoma cell | - | 22529849 |
| RLID00029546 | Circulating | Serum | Next-generation sequencing | 22719975 |
| RLID00029547 | Exosome | Mast cell | Microarray | 24009880 |